Apoptosis-associated signaling pathways are required for chemotherapy- mediated female germ cell destruction

Nature Medicine

Volumn 3, Issue 11, 1997, Pages 1228-1232

  Perez, Gloria I ^a   Knudson, C Michael ^b   Leykin, Lucy ^a   Korsmeyer, Stanley J ^b   Tilly, Jonathan L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL DEATH; CONTROLLED STUDY; FEMALE STERILITY; GERM CELL; MOUSE; NONHUMAN; OOCYTE; OVARY CELL; PLOIDY; PRIORITY JOURNAL;

ANIMALIA;

EID: 0030694255     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1197-1228     Document Type: Article

References (48)

1. Waxman, J. Chemotherapy and the adult gonad: A review. J. R. Soc. Med. 76, 144-148 (1983).
2. Familiari, G. et al. Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin's disease. Hum. Reprod. 8, 2080-2087 (1993).
3. Ried, H.L. & Jaffe, N. Radiation-induced changes in long-term survivors of childhood cancer after treatment with radiation therapy. Semin. Roentgenol. 29, 6-14 (1994).
4. Reichman, B.S. & Green, K.B. Breast cancer in young women: Effect of chemotherapy on ovarian function, fertility and birth defects. Monogr. Natl. Cancer Inst. 16, 125-129 (1994).
5. Gougeon, A. Regulation of ovarian follicular development in primates: Facts and hypotheses. Endocr. Rev. 17, 121-155 (1996).
6. Tucker, M.J., Morton, P.C., Sweitzer, C.L. & Wright, G. Cryopreservation of human embryos and oocytes. Curr. Opin. Obstet. Gynecol. 7, 188-192 (1995).
7. Tilly, J.L. & Ratts, V.S. Biological and clinical importance of ovarian cell death. Contemp. Obstet. Gynecol. 41, 59-86 (1996).
8. Tilly, J.L. Apoptosis and ovarian function. Rev. Reprod. 1, 162-172 (1996).
9. Tilly, J.L., Tilly, K.I. & Perez, G.I. The genes of cell death and cellular susceptibility to apoptosis in the ovary: A hypothesis. Cell Death Differ. 4, 180-187 (1997).
10. Reed, J.C. Bcl-2 and the regulation of programmed cell death J. Cell Biol. 124, 1-6 (1994).
11. Wyllie, A.H. The genetic regulation of apoptosis. Curr. Opin. Genet. Dev. 5, 97-104 (1995).
12. Yang, E. & Korsmeyer S.J. Molecular thanatopsis: A discourse on the BCL-2 family and cell death. Blood 88, 386-401 (1996).
13. Tilly, K.I., Banerjee, S., Banerjee, P.P. & Tilly, J.L. Expression of the p53 and Wilms' tumor suppressor genes in the rat ovary: Gonadotropin repression in vivo and immunohistochemical localization of nuclear p53 protein to apoptotic granulosa cells of atretic follicles. Endocrinology 136, 1394-1402 (1995).
14. Keren-Tal, I. et al. Involvement of p53 expression in cAMP-mediated apoptosis in immortalized granulosa cells. Exp. Cell Res. 218, 283-295 (1995).
15. long messenger ribonucleic acid levels. Endocrinology 136, 232-241 (1995).
16. Ratts, V.S., Flaws, J.A., Kolp, R., Sorenson, C.M. & Tilly, J.L Ablation of bcl-2 gene expression decreases the number of oocytes and primordial follicles established in the post-natal female mouse gonad. Endocrinology 136, 3665-3668 (1995).
17. Knudson, C.M., Tung, K.S.K., Tourtellote, W.G., Brown, G.A.J. & Korsmeyer, S.J. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270, 96-99 (1995).
18. Kugu, K. et al. Analysis of apoptosis and expression of bcl-2 gene family members in the human and baboon ovary. Cell Death Differ. (in the press).
19. Alnemri, E.S. et al. Human ICE/CED-3 protease nomenclature. Cell 87, 171 (1996).
20. Flaws, J.A. et al. Interleukin-1β-converting enzyme-related proteases (IRPs) and mammalian cell death: Dissociation of IRP-induced oligonucleosomal endonuclease activity from morphological apoptosis in granulosa cells of the ovarian follicle. Endocrinology 116, 5042-5053 (1995).
21. Maravei, D.V. et al. Cleavage of cytoskeletal proteins by caspases during ovarian cell death: Evidence that cell-free systems do not always mimic apoptotic events in intact cells. Cell Death Differ. (in the press).
22. Spiegel, S., Foster, D. & Kolesnick, R.N. Signal transduction through lipid second messengers. Curr. Opin. Cell Biol. 8, 159-167 (1996).
23. Hannun, Y.A. Function of ceramide in coordinating cellular responses to stress. Science 274, 1855-1859 (1996).
24. Witty, J.P., Bridgham, J.T. & Johnson, A.L. Induction of apoptotic cell death in hen granulosa cells by ceramide. Endocrinology 137, 5269-5277 (1996).
25. Kaipia, A., Chun, S., Eisenhauer, K. & Hsueh, A.J.W. Tumor necrosis factor-α and its second messenger, ceramide, stimulate apoptosis in cultured ovarian follicles. Endocrinology 137, 4864-4870 (1996).
26. Martimbeau, S. & Tilly, J.L. Physiological cell death in endocrine-dependent tissues: An ovarian perspective. Clin. Endocrinol. 46, 241-254 (1997).
27. Alberts, D.S., Bachur, N.R. & Holtzman, J.L. The pharmokinetics of daunomycin in man. Clin. Pharmacol. Ther. 12, 96-104 (1971).
28. Speth, P.A., van Hoesel, Q.G. & Haanen, C. Clinical pharmokinetics of doxorubicin. Clin. Pharmokinetics 15, 15-31 (1988).
29. Bose, R. et al. Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals. Cell 82, 405-414 (1995).
30. Jaffrezou, J.P. et al. Daunorubicin-induced apoptosis: Triggering of ceramide generation through sphingomyelin hydrolysis. EMBO J. 15, 2417-2424 (1996).
31. Wang, E., Norred, W.P., Bacon, C.W., Riley, R.T. & Merril, A.H. Inhibition of sphingolipid biosynthesis by fumonisins. J. Biol. Chem. 266, 14486-14490 (1991).
32. Cuvillier, O. et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381, 800-803 (1996).
33. Oltvai, Z.N., Milliman, C.L. & Korsmeyer, S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619 (1993).
34. Yin, C., Knudson, C.M., Korsmeyer, S.J. & Van Dyke, T. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385, 637-640 (1997).
35. McCurrach, M.E., Connor, T.M.F., Knudson, C.M., Korsmeyer, S.J. & Lowe, S.W. bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA 94, 2345-2349 (1997).
36. Tchang, F., Gusse, M., Soussi, T. & Mechali, M. Stabilization and expression of high levels of p53 during early development in Xenopus laevis. Dev. Biol. 159, 163-172 (1993).
37. Lowe, S.W., Ruley, H.E., Jacks, T. & Housman, D.E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957-967 (1993).
38. Lane, D.P., Lu, X., Hupp, T. & Hall, P.A. The role of the p53 protein in the apoptotic response. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 345, 277-280 (1994).
39. Ko L.J. & Prives, C. p53: Puzzle and paradigm. Genes Dev. 10, 1054-1072 (1996).
40. Miyashita, T. & Reed, J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299 (1995).
41. Patel, T., Gores, G. & Kaufmann, S.H. The role of proteases during apoptosis. FASEB J. 10, 587-597 (1996).
42. Nicholson, D.W. et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376, 37-43 (1995).
43. Jacobson, M.D., Weil, M. & Raff, M.C. Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death. J. Cell. Biol. 133, 1041-1051 (1996).
44. L function upstream of the CED-3-like apoptotic proteases. J. Biol. Chem. 271, 4573-4584 (1996).
45. Xiang, J., Chao, D.T. & Korsmeyer, S.J. BAX-induced cell death may not require interleukin-1β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA 93, 14559-14563 (1996).
46. Deveraux, Q.L., Takahashi, R., Salvesen, G.S. & Reed, J.C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388, 300-304 (1997).
47. Jacobson, M.D., Burne, J.F. & Raff, M.C. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J. 13, 1899-1910 (1994).
48. Schulze-Osthoff, K., Walczak, H., Droge, W. & Krammer, P.H. Cell nucleus and DNA fragmentation are not required for apoptosis. J. Cell Biol. 127, 15-20 (1994).